AVIRAtea Pharmaceuticals, Inc.
$5.15+73% 1Y
$5.15
$2.9652 weeks$6.15
Price
+73%1YEnd-of-day closes, not the intraday tick.
RyuScore
Weak, higher than 23% of companiesThe five questions
2 of 5 availableOnly two of the five can be answered for AVIR today. The rest need figures this filer has not published. The tabs above still show whatever data does exist.
- Is the business good?not enough filed
- Is it safe?Watch
- Is the price fair?not enough filed
- Is it growing?not enough filed
- What is the market doing?Mixed
P/En/a
Market value$412.1M
1 year+73%
5 years-85%
Charts
As reported to the SEC, without any scoring.
The next results filing is expected around Nov 11, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 12, 2026Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update.Earnings release · press release
- May 12, 2026Atea Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update.Earnings release · press release
- Mar 5, 2026Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.